AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.076

+0.01116.92%

Volume:180.27K

Turnover:12.77K

Market Cap:27.97M

PE:-3.79

High:0.077

Open:0.065

Low:0.065

Close:0.065

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:3.36

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-273.29%

ROA:-50.29%

PB:-33.86

PE(LYR):-3.80

Loading ...

Overview Company News Filings

BRIEF-Bcal Diagnostics Appoints Anne-Louise Arnett As CEO

BCAL Diagnostics Ltd - Appoints Anne-Louise Arnett as CEO Effective June 1, 2026

THOMSON REUTERS

Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says

MT Newswires Live

Update: Becton, Dickinson Shares Rise After Higher Fiscal Q2 Results; Vitor Roque Named as CFO

MT Newswires Live

Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180

MT Newswires Live

Becton, Dickinson Collaborates With Wellstar Health to Improve Drug Delivery Systems

MT Newswires Live

Did BD’s All‑in‑One CVC Launch Just Shift Becton Dickinson’s (BDX) Investment Narrative?

Simply Wall St.

Is It Time To Reassess Becton Dickinson (BDX) After Recent Share Price Weakness?

Simply Wall St.

How Investors May Respond To Becton Dickinson (BDX) Expanding Clinically Differentiated Devices And Supply Chain Strength

Simply Wall St.

Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating

MT Newswires Live

RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating

MT Newswires Live

Becton, Dickinson Seeks EU Approval for New Liver Disease Stent Device

MT Newswires Live

BRIEF-BCAL Diagnostics Submits MSAC Application For Avantect Pancreatic Cancer Early Detection Blood Test

BCAL Diagnostics Ltd - Submits Msac Application for Avantect Pancreatic Cancer Early Detection Blood Test

THOMSON REUTERS

Argus Research Adjusts Becton, Dickinson and Company Price Target to $180 From $230, Maintains Buy Rating

MT Newswires Live

Is There Now An Opportunity In Becton Dickinson (BDX) After Recent Share Price Weakness

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/BDX.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.076,"timestamp":1789020720000,"preClose":0.065,"halted":0,"volume":180266,"delay":0,"changeRate":0.16923076923076916,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.020055,"marketStatus":"Not Yet Opened","change":0.011,"latestTime":"09-10 16:12:00 AEST","open":0.065,"high":0.077,"low":0.065,"amount":12772,"amplitude":0.184615,"askPrice":0.076,"askSize":929,"bidPrice":0.068,"bidSize":93504,"shortable":3,"etf":0,"ttmEps":-0.020055,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.065,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":3.358673,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BDX.AU","preClose":0.065,"auctionPrice":0.076,"auctionVolume":5071,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020586342}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-50.29%","roe":"-273.29%","lyrEps":-0.02,"volumeRatio":3.358673,"shares":368067640,"dividePrice":0,"high":0.077,"amplitude":0.184615,"preClose":0.065,"low":0.065,"week52Low":0.052,"pbRate":"-33.86","psRate":"11.89","week52High":0.155,"institutionHeld":0,"latestPrice":0.076,"committee":0.980325,"eps":-0.020055,"divideRate":0,"volume":180266,"delay":0,"ttmEps":-0.020055,"open":0.065,"prevYearClose":0.105,"prevWeekClose":0.069,"prevMonthClose":0.066,"prevQuarterClose":0.075,"fiveDayClose":0.069,"twentyDayClose":0.056,"sixtyDayClose":0.093},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-03","symbol":"BDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788393600000,"name":null,"time":"","dateTimestamp":1788357600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634478173","title":"BRIEF-Bcal Diagnostics Appoints Anne-Louise Arnett As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2634478173","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634478173?lang=en_us&edition=fundamental","pubTime":"2026-05-11 09:48","pubTimestamp":1778464136,"startTime":"0","endTime":"0","summary":"BRIEF-Bcal Diagnostics Appoints Anne-Louise Arnett As CEOMay 11 (Reuters) - BCAL Diagnostics Ltd BDX.AX:BCAL APPOINTS ANNE-LOUISE ARNETT AS CHIEF EXECUTIVE OFFICERAPPOINTS ANNE-LOUISE ARNETT AS CEO EFFECTIVE JUNE 1, 2026Further company coverage: BDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUE22DFK6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634421000","title":"BCAL Diagnostics Ltd - Appoints Anne-Louise Arnett as CEO Effective June 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634421000","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634421000?lang=en_us&edition=fundamental","pubTime":"2026-05-11 06:24","pubTimestamp":1778451843,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260510:nTUE22DFK6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634657494","title":"Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2634657494","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634657494?lang=en_us&edition=fundamental","pubTime":"2026-05-09 01:16","pubTimestamp":1778260602,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company  is showing signs of growth recovery as the company delivered a clean fiscal Q2 beat and raised its fiscal 2026 EPS outlook, RBC Capital Markets said in a note emailed Friday.The firm said the Q2 beat is a positive indicator of improving business performance, with growth across multiple platforms. Meanwhile, the company's growth recovery back into mid-single-digit profile is yet to be proven out, it added.RBC said known headwinds such as Alaris, China and vaccines are playing out as anticipated and should ease over time.The company remains focused on share repurchases, returning about $2.3 billion to shareholders during the quarter, analysts noted.The firm also highlighted momentum in biologic, GLP-1 delivery systems and Pyxis Pro, which it said is generating strong early competitive traction.RBC maintained its sector perform rating on Becton, Dickinson and a $175 price target.Price: 148.13, Change: -5.13, Percent Change: -3.35","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX.AU","LU1059921491.USD","LU1854104046.USD","LU0130518102.USD","LU1201861165.SGD","LU1854103824.USD","BK4082","LU0648000940.SGD","LU1571399168.USD","LU1150488218.USD","LU0072461881.USD","LU1489326972.SGD","LU0266013472.USD","LU0511384066.AUD","LU0433182093.SGD","BK4585","LU0985320562.USD","BK7067","BDX","BK4504","LU0006061336.USD","LU1150488135.SGD","LU0068578508.USD","LU0289739343.SGD","LU0130103400.USD","LU0477156797.USD","LU1894683264.USD","LU0985489474.SGD","BK4588","IE00BFXG1179.USD","LU0162691827.USD","LU1894683348.USD","LU0878866978.SGD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633178837","title":"Update: Becton, Dickinson Shares Rise After Higher Fiscal Q2 Results; Vitor Roque Named as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2633178837","media":"MT Newswires Live","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633178837?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:21","pubTimestamp":1778178074,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  shares were up 5.6% in Thursday trading after the company reported higher fiscal Q2 results and named Vitor Roque as CFO.The company reported fiscal Q2 adjusted earnings Thursday of $2.90 per diluted share, up from $2.79 a year earlier.Analysts polled by FactSet expected $2.78.Revenue for the quarter ended March 31 was $4.71 billion, up from $4.48 billion a year earlier.Analysts surveyed by FactSet expected $4.67 billion.For 2026, the company raised its adjusted diluted EPS guidance to between $12.52 and $12.72, from its previous projection of $12.35 to $12.65. Analysts polled by FactSet expect $12.49. The company maintained its low single-digit plus revenue growth outlook.The company also said it has named interim Chief Financial Officer Vitor Roque to the post permanently, effective immediately.Roque has more than 25 years of experience and has held senior finance and operations roles in the company, Becton, Dickinson said.Price: 153.28, Change: +8.52, Percent Chan","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX.AU","LU0162691827.USD","LU0648000940.SGD","BK4504","LU1489326972.SGD","LU0985489474.SGD","BK4585","LU0072461881.USD","LU1854103824.USD","LU1894683264.USD","IE00BFXG1179.USD","LU0266013472.USD","LU0289961442.SGD","LU0130103400.USD","LU0289739343.SGD","LU0878866978.SGD","LU1150488218.USD","LU0130518102.USD","LU1854104046.USD","LU0477156797.USD","LU1894683348.USD","LU0985320562.USD","LU1571399168.USD","LU0068578508.USD","LU1059921491.USD","BK4082","LU1201861165.SGD","BK4588","LU0433182093.SGD","BDX","LU1150488135.SGD","LU0511384066.AUD","LU0006061336.USD","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633122538","title":"Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180","url":"https://stock-news.laohu8.com/highlight/detail?id=2633122538","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633122538?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:34","pubTimestamp":1778171697,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $181, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739343.SGD","BK4504","LU0433182093.SGD","LU1894683348.USD","LU1571399168.USD","LU1489326972.SGD","LU1894683264.USD","IE00BFXG1179.USD","LU0072461881.USD","LU0511384066.AUD","LU0985489474.SGD","LU0068578508.USD","LU1150488218.USD","LU0648000940.SGD","LU1201861165.SGD","BK4588","LU0006061336.USD","BK4585","BDX.AU","LU0162691827.USD","LU0130103400.USD","LU0289961442.SGD","LU0985320562.USD","LU1150488135.SGD","LU0266013472.USD","BDX","BK4082","BK7067","LU1854104046.USD","LU1854103824.USD","LU0477156797.USD","LU0878866978.SGD","LU1059921491.USD","LU0130518102.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633894912","title":"Becton, Dickinson Collaborates With Wellstar Health to Improve Drug Delivery Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2633894912","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633894912?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:28","pubTimestamp":1777991294,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) said Tuesday it has formed a strategic partnership with Wellstar Health System to improve the safety and quality of medication delivery across hospitals and care fa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1854103824.USD","LU0006061336.USD","LU0433182093.SGD","LU0130103400.USD","LU1150488135.SGD","BK4585","LU1894683348.USD","BK4504","BDX","LU0130518102.USD","BK4588","LU0068578508.USD","LU0985489474.SGD","LU1150488218.USD","LU0289961442.SGD","BDX.AU","LU0289739343.SGD","LU1489326972.SGD","BK7067","LU0648000940.SGD","LU1854104046.USD","LU0878866978.SGD","LU1571399168.USD","LU0072461881.USD","LU0266013472.USD","LU1201861165.SGD","LU1059921491.USD","LU1894683264.USD","LU0985320562.USD","LU0162691827.USD","LU0477156797.USD","BK4082","LU0511384066.AUD","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632675706","title":"Did BD’s All‑in‑One CVC Launch Just Shift Becton Dickinson’s (BDX) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632675706","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632675706?lang=en_us&edition=fundamental","pubTime":"2026-05-02 21:35","pubTimestamp":1777728948,"startTime":"0","endTime":"0","summary":"In April 2026, Becton Dickinson commercially launched the BD CentroVena One Insertion System in the U.S., the first all‑in‑one central venous catheter insertion device cleared under the FDA’s 510(k) pathway and accepted into the Safer Technologies Program.\nThe launch marks BD’s entry into the acute CVC market, potentially reshaping workflows and safety practices in high‑pressure acute care settings by consolidating multiple components into a single platform.\nWe’ll now examine how BD’s entry...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/did-bds-allinone-cvc-launch-just-shift-becton-dickinsons-bdx","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/did-bds-allinone-cvc-launch-just-shift-becton-dickinsons-bdx","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1854103824.USD","LU0985320562.USD","LU0130518102.USD","BDX.AU","LU1059921491.USD","BK4588","LU1894683264.USD","IE00BFXG1179.USD","LU0072461881.USD","LU0006061336.USD","LU1150488135.SGD","LU1571399168.USD","LU0289739343.SGD","LU0477156797.USD","LU1201861165.SGD","BK7067","LU0985489474.SGD","LU1854104046.USD","BK4082","LU0511384066.AUD","LU0433182093.SGD","LU0648000940.SGD","LU0068578508.USD","LU0130103400.USD","BDX","LU0162691827.USD","LU1894683348.USD","LU0266013472.USD","LU0878866978.SGD","LU1150488218.USD","BK4585","BK4504","LU0289961442.SGD","LU1489326972.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631265584","title":"Is It Time To Reassess Becton Dickinson (BDX) After Recent Share Price Weakness?","url":"https://stock-news.laohu8.com/highlight/detail?id=2631265584","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631265584?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:16","pubTimestamp":1777554984,"startTime":"0","endTime":"0","summary":"With Becton Dickinson trading at US$145.31, many investors are asking a simple question: is the current price giving fair value for a global medical equipment leader, or has the market moved too far in one direction?\nRecent returns, including a 6.6% decline over the last 7 days, 6.1% over 30 days, 25.5% year to date and 8.6% over the past year, suggest sentiment around the stock has shifted and may be influencing how the market is thinking about risk and opportunity.\nWhile there has not been...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-it-time-to-reassess-becton-dickinson-bdx-after-recent-sha-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-it-time-to-reassess-becton-dickinson-bdx-after-recent-sha-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0162691827.USD","LU0985320562.USD","BK4504","LU1854104046.USD","LU0289739343.SGD","LU0068578508.USD","BK4585","BK4082","LU1489326972.SGD","LU0985489474.SGD","DCF","BK7067","LU0266013472.USD","LU0433182093.SGD","LU1059921491.USD","LU1150488218.USD","LU0130103400.USD","LU0072461881.USD","LU0511384066.AUD","BDX","LU1854103824.USD","LU0648000940.SGD","LU1894683264.USD","LU1150488135.SGD","LU0477156797.USD","IE00BFXG1179.USD","LU1571399168.USD","BDX.AU","LU0878866978.SGD","LU1894683348.USD","LU0006061336.USD","LU0289961442.SGD","LU0130518102.USD","LU1201861165.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628147617","title":"How Investors May Respond To Becton Dickinson (BDX) Expanding Clinically Differentiated Devices And Supply Chain Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2628147617","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628147617?lang=en_us&edition=fundamental","pubTime":"2026-04-20 13:05","pubTimestamp":1776661513,"startTime":"0","endTime":"0","summary":"In recent weeks, Becton, Dickinson and Company has highlighted new clinical data for its PureWick Urine Collection System, launched the HemoSphere Stream Module for continuous noninvasive blood pressure monitoring, advanced its Liverty TIPS Stent Graft program in portal hypertension, and received multi-category supply chain resilience awards from the Healthcare Industry Resilience Collaborative.\nTaken together, these developments underline BD’s push into higher-value, clinically...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/how-investors-may-respond-to-becton-dickinson-bdx-expanding","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/how-investors-may-respond-to-becton-dickinson-bdx-expanding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1150488135.SGD","LU1059921491.USD","LU1894683348.USD","LU0985489474.SGD","BDX","LU1894683264.USD","LU0878866978.SGD","LU1489326972.SGD","LU0477156797.USD","LU0511384066.AUD","LU1854103824.USD","LU0985320562.USD","LU0068578508.USD","BK4588","BK7067","BK4211","LU0289961442.SGD","LU0433182093.SGD","LU0162691827.USD","LU1854104046.USD","BDX.AU","ISBC","BK4082","LU0130103400.USD","LU0006061336.USD","IE00BFXG1179.USD","LU0266013472.USD","LU1571399168.USD","LU0072461881.USD","LU0289739343.SGD","BK4585","LU0130518102.USD","LU0648000940.SGD","LU1150488218.USD","BK4504","LU1201861165.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628788845","title":"Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2628788845","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628788845?lang=en_us&edition=fundamental","pubTime":"2026-04-17 23:38","pubTimestamp":1776440280,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $186.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1059921491.USD","LU0006061336.USD","BK4588","LU0130518102.USD","LU0266013472.USD","LU0433182093.SGD","LU1150488218.USD","LU0289739343.SGD","LU1854103824.USD","LU0068578508.USD","LU0130103400.USD","LU1571399168.USD","BK4585","LU0511384066.AUD","LU0162691827.USD","BK4504","LU0878866978.SGD","LU1894683264.USD","LU1854104046.USD","BK4082","BK7067","LU0477156797.USD","LU0985489474.SGD","LU0289961442.SGD","LU0648000940.SGD","LU1201861165.SGD","BDX","BDX.AU","LU1150488135.SGD","IE00BFXG1179.USD","LU1894683348.USD","LU1489326972.SGD","LU0985320562.USD","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627144872","title":"RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2627144872","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627144872?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:27","pubTimestamp":1776166042,"startTime":"0","endTime":"0","summary":"Becton, Dickinson (BDX) has an average rating of overweight and mean price target of $187.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0985489474.SGD","BDX","LU1894683264.USD","BK7067","BK4504","LU0433182093.SGD","LU1854103824.USD","LU1854104046.USD","LU0130518102.USD","BDX.AU","LU0072461881.USD","BK4585","LU0068578508.USD","LU1059921491.USD","LU0648000940.SGD","LU0289961442.SGD","BK4082","LU1489326972.SGD","LU1894683348.USD","LU0477156797.USD","LU1150488135.SGD","LU1201861165.SGD","LU0878866978.SGD","BK4588","LU0006061336.USD","LU0162691827.USD","LU0266013472.USD","IE00BFXG1179.USD","LU0130103400.USD","LU0511384066.AUD","LU1150488218.USD","LU1571399168.USD","LU0985320562.USD","LU0289739343.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943620","title":"Becton, Dickinson Seeks EU Approval for New Liver Disease Stent Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943620","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625943620?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:09","pubTimestamp":1775646578,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said it has applied for a CE Mark in the European Union for its Liverty TIPS Stent Graft, a next-generation device designed to treat complications from portal hypertension in the liver.The company said the device targets patients with cirrhosis, a condition affecting an estimated 58 million people globally, and aims to improve outcomes by reducing elevated blood pressure in the liver through TIPS procedures.The Liverty stent features an adjustable diameter, flexible self-expanding frame, and advanced coating designed for precision placement and durability, the company added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1894683264.USD","LU0072461881.USD","LU1571399168.USD","BK4585","LU0162691827.USD","LU0130518102.USD","LU0289961442.SGD","LU1894683348.USD","BDX.AU","LU0006061336.USD","IE00BFXG1179.USD","LU0068578508.USD","LU0433182093.SGD","LU1489326972.SGD","LU1150488218.USD","BDX","LU1201861165.SGD","LU0878866978.SGD","LU0289739343.SGD","LU1854104046.USD","BK4588","BK4156","LU0266013472.USD","LU1150488135.SGD","BK7067","LU1059921491.USD","BK4082","LU0477156797.USD","LU0130103400.USD","LU0648000940.SGD","LU0985489474.SGD","LU0511384066.AUD","BK4504","LU0985320562.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623940376","title":"BRIEF-BCAL Diagnostics Submits MSAC Application For Avantect Pancreatic Cancer Early Detection Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2623940376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623940376?lang=en_us&edition=fundamental","pubTime":"2026-03-31 09:52","pubTimestamp":1774921940,"startTime":"0","endTime":"0","summary":"BRIEF-BCAL Diagnostics Submits MSAC Application For Avantect Pancreatic Cancer Early Detection Blood TestMarch 31  - BCAL Diagnostics Ltd BDX.AX:SUBMITS MSAC APPLICATION FOR AVANTECT PANCREATIC CANCER EARLY DETECTION BLOOD TESTFurther company coverage: BDX.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40I1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623322392","title":"BCAL Diagnostics Ltd - Submits Msac Application for Avantect Pancreatic Cancer Early Detection Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2623322392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623322392?lang=en_us&edition=fundamental","pubTime":"2026-03-31 06:11","pubTimestamp":1774908691,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nFWN40I1CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621703743","title":"Argus Research Adjusts Becton, Dickinson and Company Price Target to $180 From $230, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2621703743","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621703743?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:22","pubTimestamp":1774268568,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $191.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0433182093.SGD","LU0289739343.SGD","LU0068578508.USD","BDX","LU0648000940.SGD","BK4082","BK7067","LU1059921491.USD","LU1150488218.USD","LU1150488135.SGD","LU0130518102.USD","LU1201861165.SGD","LU0511384066.AUD","BK4504","LU0878866978.SGD","LU0477156797.USD","IE00BFXG1179.USD","LU1489326972.SGD","LU0072461881.USD","LU0130103400.USD","LU1854103824.USD","LU0006061336.USD","LU0289961442.SGD","BK4585","LU1894683348.USD","BK4588","LU0162691827.USD","BDX.AU","LU0985320562.USD","LU1854104046.USD","LU1571399168.USD","LU0985489474.SGD","LU0266013472.USD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619124959","title":"Is There Now An Opportunity In Becton Dickinson (BDX) After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2619124959","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619124959?lang=en_us&edition=fundamental","pubTime":"2026-03-14 22:24","pubTimestamp":1773498291,"startTime":"0","endTime":"0","summary":"If you are wondering whether Becton Dickinson's current share price reflects its true worth, you are not alone. This article will walk you through what the numbers are saying about value.\nBecton Dickinson's share price closed at US$159.36, with returns of a 4.6% decline over 7 days, an 11.8% decline over 30 days, an 18.3% decline year to date, an 8.2% decline over 1 year, a 9.0% decline over 3 years and a 5.4% decline over 5 years. This raises questions about how the market is currently...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-there-now-an-opportunity-in-becton-dickinson-bdx-after-re","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-there-now-an-opportunity-in-becton-dickinson-bdx-after-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0162691827.USD","LU0985320562.USD","BK4504","LU1854104046.USD","LU0289739343.SGD","LU0068578508.USD","BK4585","BK4082","LU1489326972.SGD","LU0985489474.SGD","DCF","BK7067","LU0266013472.USD","LU0433182093.SGD","LU1059921491.USD","LU1150488218.USD","LU0130103400.USD","LU0072461881.USD","LU0511384066.AUD","BDX","LU1854103824.USD","LU0648000940.SGD","LU1894683264.USD","LU1150488135.SGD","LU0477156797.USD","IE00BFXG1179.USD","LU1571399168.USD","BDX.AU","LU0878866978.SGD","LU1894683348.USD","LU0006061336.USD","LU0289961442.SGD","LU0130518102.USD","LU1201861165.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":56,"code":"91000000","status":"200"}]}}